Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
| Data(s) |
2011
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_6DF485773E58 isbn:1098-6596 (Electronic) pmid:21849572 doi:10.1128/AAC.00603-11 |
| Idioma(s) |
en |
| Fonte |
Antimicrobial Agents and Chemotherapy, vol. 55, no. 9, pp. 4496; author reply 4496-4496; author reply 4497 |
| Palavras-Chave | #Animals; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Endocarditis/drug therapy; Staphylococcus aureus/drug effects; Staphylococcus aureus/pathogenicity; Vancomycin/pharmacology; Vancomycin/therapeutic use |
| Tipo |
info:eu-repo/semantics/article article |
